Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients

被引:116
作者
Falagas, Matthew E. [1 ,2 ,3 ]
Rafailidis, Petros I. [1 ,2 ]
Matthaiou, Dimitrios K. [1 ]
Virtzili, Simona
Nikita, Dimitra [4 ]
Michalopoulos, Argyris
机构
[1] Alfa Inst Biomed Sci, Athens 15123, Greece
[2] Henry Dunant Hosp, Dept Med, Athens, Greece
[3] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[4] Henry Dunant Hosp, Dept Microbiol, Athens, Greece
关键词
Carbapenem; Meropenem; Imipenem; Ciprofloxacin; Colistin; Klebsiella pneumoniae; Pseudomonas aeruginosa; Acinetobacter baumannii; Gram-negative; Mortality; Polymyxins; Pandrug resistance; Multiple drug resistance;
D O I
10.1016/j.ijantimicag.2008.05.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We describe the characteristics and outcome of pandrug-resistant (PDR) Gram-negative bacterial infections (23 Klebsiella pneumoniae isolates, 3 Pseudomonas aeruginosa and 3 Acinetobacter baumannii) of hospitalised patients at a tertiary-care centre (1 January 2006-31 May 2007). The site of infection was central venous catheter-related in 5 of 24 patients with clinical infection, bacteraemia in 5, the respiratory system in 5, surgical site in 5, the urinary systemin 2, the ascitic fluid in 1 and the central nervous system in one. Twenty of 24 patients with infection received an antibiotic regimen containing colistin (in combination with meropenem in 8 patients). The overall in-hospital mortality was 41.7% (10/24); 8 patients died because of the PDR infection (infection-related mortality 33.3%). Significant co-morbidity was present not only in the patients who died but also in survivors. PDR Gram-negative bacterial infections are associated with considerable mortality, although not as high as expected given the fact that the isolates were resistant to all tested antibiotics, including polymyxins. Antibiotics that are ineffective in vitro may prove life-saving for some of these patients, especially combination regimens containing colistin. (C) 2008 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:450 / 454
页数:5
相关论文
共 16 条
[1]  
[Anonymous], HOSP EPIDEMIOLOGY IN
[2]   Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients:: first report of a multiclonal cluster [J].
Antoniadou, Anastasia ;
Kontopidou, Flora ;
Poulakou, Garifalia ;
Koratzanis, Evangelos ;
Galani, Irene ;
Papadomichelakis, Evangelos ;
Kopterides, Petros ;
Souli, Maria ;
Armaganidis, Apostolos ;
Giamarellou, Helen .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) :786-790
[3]   Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin [J].
Beno, P ;
Krcmery, V ;
Demitrovicova, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (05) :497-498
[4]   Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents [J].
Bratu, S ;
Tolaney, P ;
Karumudi, U ;
Quale, J ;
Mooty, M ;
Nichani, S ;
Landman, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :128-132
[5]  
*BRIT SOC ANT CHEM, 2007, BSAC METH ANT SUSC T
[6]   Occurrence of carbapenern-resistant Acinetobacter baumannii clones at multiple hospitals in London and southeast England [J].
Coelho, Juliana M. ;
Turton, Jane F. ;
Kaufmann, Mary E. ;
Glover, Judith ;
Woodford, Neil ;
Warner, Marina ;
Palepou, Marie-France ;
Pike, Rachel ;
Pitt, Tyrone L. ;
Patel, Bharat C. ;
Livermore, David M. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (10) :3623-3627
[7]   Attributable mortality of Acinetobacter baumannii:: no longer a controversial issue [J].
Falagas, Matthew E. ;
Rafailidis, Petros I. .
CRITICAL CARE, 2007, 11 (03)
[8]   The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa [J].
Falagas, Matthew E. ;
Koletsi, Patra K. ;
Bliziotis, Ioannis A. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (12) :1619-1629
[9]   Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria [J].
Falagas, ME ;
Bliziotis, IA ;
Kasiakou, SK ;
Samonis, G ;
Athanassopoulou, P ;
Michalopoulos, A .
BMC INFECTIOUS DISEASES, 2005, 5 (1)
[10]   Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [J].
Falagas, ME ;
Kasiakou, SK .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1333-1341